Arceci RJ - Search Results

1

Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

Strouse JJ, Spevak M, Mack AK, Arceci RJ, Small D, Loeb DM. Strouse JJ, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2005 Apr;44(4):407-11. doi: 10.1002/pbc.20292. Pediatr Blood Cancer. 2005. PMID: 15602719 Review.

2

Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.

Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B, Arceci R, Small D. Brown P, et al. Blood. 2004 Sep 15;104(6):1841-9. doi: 10.1182/blood-2004-03-1034. Epub 2004 May 27. Blood. 2004. PMID: 15166029 Free article.

3

Treatment and outcome of infants with acute myeloid leukemia.

Loeb DM, Arceci RJ. Loeb DM, et al. Among authors: arceci rj. Blood. 2002 Apr 1;99(7):2626-7. doi: 10.1182/blood-2001-12-0337. Blood. 2002. PMID: 11926186 Free article. No abstract available.

4

What is the optimal therapy for childhood AML?

Loeb DM, Arceci RJ. Loeb DM, et al. Among authors: arceci rj. Oncology (Williston Park). 2002 Aug;16(8):1057-66; discussion 1066, 1068-70. Oncology (Williston Park). 2002. PMID: 12201645 Free article. Review.

5

WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group.

Noronha SA, Farrar JE, Alonzo TA, Gerbing RB, Lacayo NJ, Dahl GV, Ravindranath Y, Arceci RJ, Loeb DM. Noronha SA, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2009 Dec;53(6):1136-9. doi: 10.1002/pbc.22142. Pediatr Blood Cancer. 2009. PMID: 19618455 Free PMC article.

6

The incidence and clinical significance of nucleophosmin mutations in childhood AML.

Brown P, McIntyre E, Rau R, Meshinchi S, Lacayo N, Dahl G, Alonzo TA, Chang M, Arceci RJ, Small D. Brown P, et al. Among authors: arceci rj. Blood. 2007 Aug 1;110(3):979-85. doi: 10.1182/blood-2007-02-076604. Epub 2007 Apr 17. Blood. 2007. PMID: 17440048 Free PMC article.

7

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line.

Moore JB 4th, Loeb DM, Hong KU, Sorensen PH, Triche TJ, Lee DW, Barbato MI, Arceci RJ. Moore JB 4th, et al. Among authors: arceci rj. Front Cell Dev Biol. 2015 Mar 9;3:15. doi: 10.3389/fcell.2015.00015. eCollection 2015. Front Cell Dev Biol. 2015. PMID: 25806369 Free PMC article.

8

Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.

Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ. Williams KM, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2008 Mar;50(3):667-70. doi: 10.1002/pbc.21171. Pediatr Blood Cancer. 2008. PMID: 17318876

9

Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.

Schafer E, Chen A, Arceci RJ. Schafer E, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2009 Dec;53(6):1127-9. doi: 10.1002/pbc.22129. Pediatr Blood Cancer. 2009. PMID: 19479793 Free PMC article.

10

Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias.

Abd Elmoneim A, Gore L, Ricklis RM, Boklan J, Cooper T, Narendran A, Rolla K, Scott T, Arceci RJ. Abd Elmoneim A, et al. Among authors: arceci rj. Pediatr Blood Cancer. 2012 Dec 15;59(7):1252-8. doi: 10.1002/pbc.24264. Epub 2012 Aug 8. Pediatr Blood Cancer. 2012. PMID: 22887831 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters